The business case for expanded clozapine utilization: In reply

Jessica L. Gören; Adam J. Rose; John P. Ney

doi:10.1176/appi.ps.68303

The business case for expanded clozapine utilization: In reply

Jessica L. Gören, Adam J. Rose, John P. Ney

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	309-310
Number of pages	2
Journal	Psychiatric Services
Volume	68
Issue number	3
DOIs	https://doi.org/10.1176/appi.ps.68303
State	Published - 1 Mar 2017
Externally published	Yes

All Science Journal Classification (ASJC) codes

Psychiatry and Mental health

Access to Document

10.1176/appi.ps.68303

Cite this

@article{54255ae4ed4c42dfb76267a9443e6793,

title = "The business case for expanded clozapine utilization: In reply",

author = "G{\"o}ren, \{Jessica L.\} and Rose, \{Adam J.\} and Ney, \{John P.\}",

year = "2017",

month = mar,

day = "1",

doi = "10.1176/appi.ps.68303",

language = "الإنجليزيّة",

volume = "68",

pages = "309--310",

journal = "Psychiatric Services",

issn = "1075-2730",

publisher = "American Psychiatric Association",

number = "3",

}

TY - JOUR

T1 - The business case for expanded clozapine utilization

T2 - In reply

AU - Gören, Jessica L.

AU - Rose, Adam J.

AU - Ney, John P.

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85014121162&partnerID=8YFLogxK

U2 - 10.1176/appi.ps.68303

DO - 10.1176/appi.ps.68303

M3 - رسالة

C2 - 28240155

SN - 1075-2730

VL - 68

SP - 309

EP - 310

JO - Psychiatric Services

JF - Psychiatric Services

IS - 3

ER -

The business case for expanded clozapine utilization: In reply

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this